Global Precision Medical Imaging Market Overview
Precision medical imaging concept covers a broad range of applications, from the molecular imaging of theranostic radiotracers to the use of scans to create custom, 3D-printed implants. The global precision medical imaging market accounted for US$ 4.5 billion in 2019 and is estimated to be US$ 9.0 billion by 2029 and is anticipated to register a CAGR of 7.4%.
Impact of COVID-19 on the market
The outbreak of COVID-19 has raised the demand for a number of kits and rapid tests. As screening is being performed at a massive scale during this outbreak hotspot. There is a huge demand for Covid-19 screening as a crucial factor for revenue growth in this market space. Additionally, increasing cases of COVID-19 patients attributes to increasing number of hospitals as well as treatment centers. Thus, increasing incidence of hospitalization, technological advancement in hospital beds, and increasing healthcare expenditure are boosting the patient infotainment terminal market growth. This report will quantify the impact of this pandemic on the precision medical imaging market.
Global Precision Medical Imaging Market Dynamics
Rising outreach in emerging markets, increasing innovations in technology, growing research and development, and adoption of strategies such as collaboration are projected to dive growth of the precision medicine imaging market in the coming years.
Key players are focusing on innovation to expand their developing markets. For instance, Strata Oncology, Inc. and Synapse, Inc. together, launched an end-to-end precision oncology program to enhance outcomes of the treatment with reduced costs, as the firms are selecting the most promising precision medicine clinical trials. Further, in May 2017, Strata Oncology, Inc. also introduced Strata NGS test, which is manufactured for 90 gene targeted assay that deals on genetic alterations in tumor tissue and includes clinical trial eligibility markers and tumor markers. In August 2017, the U.S. Food and Drug Administration approved the first gene therapy, Kymriah (tisagenlecleucel). This therapy was developed by Novartis for the treatment of patients below 25 years of age with B-cell precursor acute lymphoblastic leukemia. It signifies a shift from chemotherapy to precision medicine. In 2016, AstraZeneca developed a next-generation asthma drug, Benralizumab, for eosinophil biomarker. It is a part of the new biological treatments for people with asthma, as AstraZeneca is shifting towards precision medicine to cure the disease.
However, lack of reimbursement policy limits growth of the precision medicine market.
Global Precision Medical Imaging Market Segmentation
The precision medical imaging market is segmented based on the application and region.
On the basis of the application, the precision medical imaging market is segmented into cardiovascular, neurology, gastroenterology, infectious diseases, oncology, and other.
Regional Insights:
In the region, the precision medical imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America estimated for essential share in precision imaging market, owing to the established health care infrastructure, excessive healthcare expenditure, and consciousness in early diagnosis of diseases. Asia-Pacific precision imaging market is expected to register tremendous growth due to the presence of rising markets like India and China along with growing medical tourism due to modernization of hospitals and low prognosis costs in this country. In Europe region, Germany has a main share in precision medical imaging market. In the Middle East and Africa place, South Africa is measured as one in all the largest markets because of the excessive occurrence of diverse illnesses.
Report Scope:
|
Attribute |
Details |
|
The base year for estimation |
2019 |
|
Forecast period |
2019 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 – 2029 |
|
Market Segmentation |
By Application - Cardiovascular, Neurology, Gastroenterology, Infectious Diseases, Oncology, and Other |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global precision medical imaging market report based on application and region.
Precision Medical Imaging Market, By Application:
- Cardiovascular
- Neurology
- Gastroenterology
- Infectious Diseases
- Oncology
- Other
Precision Medical Imaging Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Precision Medical Imaging Market Key Players
The key players operating in the precision medical imaging market include Ferrer Incode, Nanostring Technologies, Inc., Pfizer, Inc., Tepnel Pharma Services, Novartis AG, Teva Pharmaceutical Industries Ltd., Qiagen N.V., Merck & Co., Inc., and Quest Diagnostics. Manufacturers in the precision medicine imaging market are undertaking strategies such as collaboration to improve their product portfolio. For instance, in September 2019, Precision for Medicine Group, Inc. completed the acquisition of Agility Clinical, a contract research organization that emphasizes on clinical development of rare diseases and orphan therapies. The aim of the acquisition was to bring new precision medicines into the market.
Global Precision Medical Imaging Market Company Profile
- Ferrer Incode
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Nanostring Technologies, Inc.
- Pfizer, Inc.
- Tepnel Pharma Services
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Qiagen N.V.
- Merck & Co., Inc.
- Quest Diagnostics
“*” marked represents similar segmentation in other categories in the respective section
Global Precision Medical Imaging Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Precision Medical Imaging Strategies
- Key Questions this Study will Answer
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Precision Medical Imaging Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Cardiovascular
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Neurology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Gastroenterology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Infectious Diseases
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Precision Medical Imaging Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Ferrer Incode
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Nanostring Technologies, Inc.
- Pfizer, Inc.
- Tepnel Pharma Services
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Qiagen N.V.
- Merck & Co., Inc.
- Quest Diagnostics
- Ferrer Incode
-
- The Last Word
- Future Impact
- About Us
- Contact